发布于: 雪球转发:0回复:0喜欢:0
回复@laxmipriya: 时间成本同样宝贵,要联系仓位组合衡量耐心与否,赛托瑞目前不是我重仓品种,之所以没有重仓就是出于对时间成本的考虑[赞成]//@laxmipriya:回复@szmayun:[鼓鼓掌]好有耐心的人啊!
引用:
2014-06-23 10:45
2014年6月18日
尊敬的投资者:
Enrollment has been completed in a pilottrial evaluating Cytori Cell Therapy as a potential adjunctive therapy for thetreatment of anterior cruciate ligament (ACL) injury. The study is led by RamonCugat, M.D. PhD with a multidisciplinary t...